85
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Magnetically stimulated ciprofloxacin release from polymeric microspheres entrapping iron oxide nanoparticles

&
Pages 4447-4458 | Published online: 09 Jul 2015

References

  • PankhurstQAConnollyJJonesSKDobsonJApplications of magnetic nanoparticles in biomedicineJ Phys D Appl Phys200336R167R181
  • BerryCCCurtisASGFunctionalisation of magnetic nanoparticles for applications in biomedicineJ Phys D Appl Phys200336R198R206
  • MorozPJonesSKGrayBNMagnetically mediated hyperthermia: current status and future directionsInt J Hyperthermia200218426728412079583
  • MahmoudiMSimchiAMilaniASStroevePCell toxicity of super-paramagnetic iron oxide nanoparticlesJ Colloid Interface Sci2009336251051819476952
  • CoeyJMDMagnetism and Magnetic MaterialsCambridgeCambridge University Press2010
  • HoareTSantamariaJGoyaGFA magnetically triggered composite membrane for on-demand drug deliveryNano Lett20099103651365719736912
  • TaiLATsaiPJWangYCWangYJLoLWYangCSThermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug releaseNanotechnology2009201313510119420485
  • Muller-SchulteDSchmitz-RodeTThermosensitive magnetic polymer particles as contactless controllable drug carriersJ Magn Magn Mater20063021267271
  • ZhangJMisraRDMagnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release responseActa Biomater20073683885017638599
  • HuS-HTsaiC-HLiaoC-FLiuD-MChenS-YControlled rupture of magnetic polyelectrolyte microcapsules for drug deliveryLangmuir20082420118111181818808160
  • HuS-HChenS-YLiuD-MHsiaoC-SCore/single-crystal-shell nanospheres for controlled drug release via a magnetically triggered rupturing mechanismAdv Mater200820142690269525213891
  • HuS-HLiuT-YHuangH-YLiuD-MChenS-YMagnetic-sensitive silica nanospheres for controlled drug releaseLangmuir200724123924418052081
  • DilnawazFSinghAMohantyCSahooSKDual drug loaded super-paramagnetic iron oxide nanoparticles for targeted cancer therapyBiomaterials201031133694370620144478
  • LiRWuRZhaoLFolate and iron difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cellsCarbon N Y201149517971805
  • SubbiahdossGSharifiSGrijpmaDWMagnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococciActa Biomater2012862047205522406508
  • SirivisootSParetaRAWebsterTJA conductive nanostructured polymer electrodeposited on titanium as a controllable, local drug delivery platformJ Biomed Mater Res A201199458659721953843
  • SirivisootSParetaRWebsterTJElectrically controlled drug release from nanostructured polypyrrole coated on titaniumNanotechnology201122808510121242621
  • SirivisootSHarrisonBSSkeletal myotube formation enhanced by electro-spun polyurethane carbon nanotube scaffoldsInt J Nanomedicine201162483249722072883
  • XuHChengLWangCMaXLiYLiuZPolymer encapsulated upcon-version nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug deliveryBiomaterials201132359364937321880364
  • WangSGuoSChengLDisodium norcantharidate loaded poly([var epsilon]-caprolactone) microspheres: I. Preparation and evaluationInt J Pharm20083501–213013717900833
  • PittCGPoly(ε-caprolactone) and its copolymersChasinMLangerRBiodegradable Polymer as Drug Delivery SystemsNew York, NYMarcel Decker Inc199071120
  • KimSYLeeYMTaxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriersBiomaterials200122131697170411396872
  • LamprechtATorresHRSchäferULehrC-MBiodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel diseaseJ Control Release200069344545411102684
  • LamprechtAUbrichNHombreiro PérezMLehrCHoffmanMMaincentPInfluences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization techniqueInt J Pharm2000196217718210699713
  • GristinaAGBiomaterial-centered infection: microbial adhesion versus tissue integrationScience19872374822158815953629258
  • KhalilHWilliamsRJStenbeckGHendersonBMeghjiSNairSPInvasion of bone cells by Staphylococcus epidermidisMicrobes Infect20079446046517331787
  • StrattonCFluoroquinolone antibiotics: properties of the class and individual agentsClin Ther19921433483751638577
  • JeongYINaHSSeoDHCiprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activityInt J Pharm20083521–231732318160236
  • ArmstrongEPFriedmanADBone and joint infectionsDiPiroJTTalbertRLYeeGCPharmacotherapy: A Pathophysiologic Approach8th edNew York, NYMcGraw-Hill201120292039
  • LewDPWaldvogelFAUse of quinolones in osteomyelitis and infected orthopaedic prosthesisDrugs199958Suppl 2859110553713
  • Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational SupplementWayne, PAClinical and Laboratory Standards Institute2006 CLSI document M100-S161-56238-625-5
  • WiegandIHilpertKHancockREAgar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNat Protoc20083216317518274517
  • Pascual-RegueraMIParrasGPDiampAMSolid-phase UV spectro-photometric method for determination of ciprofloxacinMicrochem J20047717984
  • KangYSRisbudSRaboltJFStroevePSynthesis and characterization of nanometer-size Fe3O4 and γ-Fe2O3 particlesChem Mater1996822092211
  • BeeAMassartRNeveuSSynthesis of very fine maghemite particlesJ Magn Magn Mater199514969
  • LodeHEvidence of different profiles of side effects and drug-drug interactions among the quinolones – the pharmacokinetic standpointChemotherapy200147Suppl 32431 discussion 44–4811549786
  • MasadehMMKarasnehGAAl-AkhrasMACerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteriaCytotechnology201567342743524643389
  • HeSFengYGuNZhangYLinXThe effect of γ-Fe2O3 nanoparticles on Escherichia coli genomeEnviron Pollut201115923468347321917366
  • AzamAAhmedASOvesMKhanMSHabibSSMemicAAntimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative studyInt J Nanomedicine201276003600923233805
  • RakshitSSarkarDElzingaEJPunamiyaPDattaRMechanisms of ciprofloxacin removal by nano-sized magnetiteJ Hazard Mater2013246–24722122623313895
  • TangYGuoHXiaoLYuSGaoNWangYSynthesis of reduced graphene oxide/magnetite composites and investigation of their adsorption performance of fluoroquinolone antibioticsColloids Surf A Physicochem Eng Asp20134247480
  • WoodruffMAHutmacherDWThe return of a forgotten polymer – polycaprolactone in the 21st centuryProg Polym Sci20103512171256
  • SinhaVRBansalKKaushikRKumriaRTrehanAPoly-ε-caprolactone microspheres and nanospheres: an overviewInt J Pharm2004118123
  • BosworthLADownesSPhysicochemical characterization of degrading polycaprolactone scaffoldsPolym Degrad Stab20109522692276
  • SobczakMSynthesis and characterization of polyester conjugates of ciprofloxacinEur J Med Chem2010453844384920541292
  • PugaAMRey-ricoAMagarinosBAlvarez-LorenzoCConcheiroAHot melt poly-e-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacinActa Biomater2012841507151822251935
  • LamCXFTeohSHHutmacherDWComparison of the degradation of polycaprolactone and polycaprolactone–(beta-tricalcium phosphate) scaffolds in alkaline mediumPolym Int200756718728